Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study L Beaugerie, N Brousse, AM Bouvier, JF Colombel, M Lémann, J Cosnes, ... The Lancet 374 (9701), 1617-1625, 2009 | 1280 | 2009 |
European evidence based consensus on the diagnosis and management of Crohn’s disease: current management SPL Travis, EF Stange, M Lémann, T Öresland, Y Chowers, A Forbes, ... Gut 55 (suppl 1), i16-i35, 2006 | 958 | 2006 |
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations G Van Assche, A Dignass, W Reinisch, CJ van der Woude, A Sturm, ... Journal of Crohn's and Colitis 4 (1), 63-101, 2010 | 957 | 2010 |
Imaging techniques for assessment of inflammatory bowel disease: joint ECCO and ESGAR evidence-based consensus guidelines J Panes, Y Bouhnik, W Reinisch, J Stoker, SA Taylor, DC Baumgart, ... Journal of Crohn's and Colitis 7 (7), 556-585, 2013 | 777 | 2013 |
Maintenance of remission among patients with Crohn's disease on antimetabolite therapy after infliximab therapy is stopped E Louis, JY Mary, G Vernier–Massouille, JC Grimaud, Y Bouhnik, ... Gastroenterology 142 (1), 63-70. e5, 2012 | 751 | 2012 |
Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial D Laharie, A Bourreille, J Branche, M Allez, Y Bouhnik, J Filippi, F Zerbib, ... The Lancet 380 (9857), 1909-1915, 2012 | 697 | 2012 |
Long-term follow-up of patients with Crohn's disease treated with azathioprine or 6-mercaptopurine Y Bouhnik, G Scemama, R Taï, C Matuchansky, JC Rambaud, M Lémann, ... The Lancet 347 (8996), 215-219, 1996 | 593 | 1996 |
Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn’s disease: a randomised, double blind, placebo controlled GETAID trial P Marteau, M Lémann, P Seksik, D Laharie, JF Colombel, Y Bouhnik, ... Gut 55 (6), 842-847, 2006 | 546 | 2006 |
Short-chain fructo-oligosaccharide administration dose-dependently increases fecal bifidobacteria in healthy humans Y Bouhnik, K Vahedi, L Achour, A Attar, J Salfati, P Pochart, P Marteau, ... The Journal of nutrition 129 (1), 113-116, 1999 | 529 | 1999 |
The capacity of nondigestible carbohydrates to stimulate fecal bifidobacteria in healthy humans: a double-blind, randomized, placebo-controlled, parallel-group, dose-response … Y Bouhnik, L Raskine, G Simoneau, E Vicaut, C Neut, B Flourié, F Brouns, ... The American journal of clinical nutrition 80 (6), 1658-1664, 2004 | 528 | 2004 |
Resistance of t(11;18) positive gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication therapy H Liu, A Ruskon-Fourmestraux, A Lavergne-Slove, H Ye, T Molina, ... The Lancet 357 (9249), 39-40, 2001 | 512 | 2001 |
Safety and efficacy of antigen-specific regulatory T-cell therapy for patients with refractory Crohn's disease P Desreumaux, A Foussat, M Allez, L Beaugerie, X Hébuterne, Y Bouhnik, ... Gastroenterology 143 (5), 1207-1217. e2, 2012 | 450 | 2012 |
Presentation and long-term follow-up of refractory celiac disease: comparison of type I with type II G Malamut, P Afchain, V Verkarre, T Lecomte, A Amiot, D Damotte, ... Gastroenterology 136 (1), 81-90, 2009 | 450 | 2009 |
Administration of transgalacto-oligosaccharides increases fecal bifidobacteria and modifies colonic fermentation metabolism in healthy humans Y Bouhnik, B Flourié, L D'Agay-Abensour, P Pochart, G Gramet, M Durand, ... The Journal of nutrition 127 (3), 444-448, 1997 | 442 | 1997 |
A randomized, double-blind, controlled withdrawal trial in Crohn’s disease patients in long-term remission on azathioprine M Lémann, JY Mary, JF Colombel, B Duclos, JC Soule, E Lerebours, ... Gastroenterology 128 (7), 1812-1818, 2005 | 430 | 2005 |
Abnormal intestinal intraepithelial lymphocytes in refractory sprue C Cellier, N Patey, L Mauvieux, B Jabri, E Delabesse, JP Cervoni, ... Gastroenterology 114 (3), 471-481, 1998 | 430 | 1998 |
Secretory IgA mediates retrotranscytosis of intact gliadin peptides via the transferrin receptor in celiac disease T Matysiak-Budnik, IC Moura, M Arcos-Fajardo, C Lebreton, S Ménard, ... The Journal of experimental medicine 205 (1), 143-154, 2008 | 412 | 2008 |
Risk factors for intra-abdominal septic complications after a first ileocecal resection for Crohn's disease: a multivariate analysis in 161 consecutive patients A Alves, Y Panis, Y Bouhnik, M Pocard, E Vicaut, P Valleur Diseases of the colon & rectum 50 (3), 331-336, 2007 | 397 | 2007 |
Role of small-bowel endoscopy in the management of patients with inflammatory bowel disease: an international OMED–ECCO consensus A Bourreille, A Ignjatovic, L Aabakken, EV Loftus Jr, R Eliakim, ... Endoscopy 41 (07), 618-637, 2009 | 395 | 2009 |
Small-bowel diseases: prospective evaluation of multi–detector row helical CT enteroclysis in 107 consecutive patients M Boudiaf, A Jaff, P Soyer, Y Bouhnik, L Hamzi, R Rymer Radiology 233 (2), 338-344, 2004 | 384 | 2004 |